The aging human immunodeficiency virus (HIV)-infected population is rapidly increasing as a result of survival gains due to improved combination antiretroviral therapy (cART) [1] and a rising incidence of HIV infections in people >50 years of age [2] . The immune dysfunction associated with HIV infection bears many similarities with the immune dysfunction attributable to aging [3] [4] [5] , and the term "immunosenescence" [6] is used to refer such dysfunction in both settings. Features common to aging and HIV infection include an increased risk for influenza virus infection [7, 8] , an impaired serologic response to influenza vaccination [9] , and a heightened state of inflammation and immune activation [6, 10, 11] . Our recent studies indicate that HIV infection and advanced age together could have a more deleterious effect on immunity than advanced age alone, based on poorer serologic responses to influenza vaccine in postmenopausal women with, versus those without, HIV infection [5, 12] .
The present study was designed to ascertain how HIV infection exacerbates the immune defects associated with aging and to understand the mechanism of the impaired antibody (Ab) response to influenza vaccination. Ab generation by B cells is dependent upon cognate help from T-follicular helper (Tfh) cells, a specialized CD4
+ T-helper cell subset in lymphoid germinal centers [13, 14] . Tfh cells play a critical role in the class-switch recombination and somatic hypermutation required for the development of memory B cells for secretion of high-affinity Ab [15, 16] . A CXCR5 + memory subset of peripheral blood CD4 + T cells with a Tfh-like helper function for B cells are known as peripheral Tfh (pTfh) cells [17, 18] . In a cohort of younger HIV-infected persons, we previously reported that influenza vaccine nonresponsiveness was associated with impaired expansion of pTfh cells, reduced plasma levels of interleukin 21 (IL-21), and lower expression of IL-21 receptor (IL-21R) on memory B cells [18] . Here, we show that, among HIV-infected and HIV-uninfected young and older women, the older HIVinfected group had the poorest serologic responses and the worst cellular functions associated with antibody production. An important role of baseline immune activation and inflammatory cytokines for inhibiting pTfh helper function for memory B-cell function was identified.
MATERIALS AND METHODS

Study Population and Samples
We conducted a study to evaluate the effect of HIV infection and aging on immune responses to influenza vaccine during the 2011-2012 influenza season. Women were considered eligible if they were >18 years of age, had no active malignancies, and were not receiving hormonal replacement therapy. Women classified as older were >55 years of age, amenorrheic for ≥12 months, and did not have a history of premenopausal oophorectomy. Women classified as young were <45 years of age and were not amenorrheic. The older participants were matched for age and for time to menopause. HIV-infected participants had been receiving cART for >6 months with virologic suppression (HIV RNA load, <100 copies/mL) [5, 12] The study was approved by the university's institutional review board, and participants were enrolled after they provided informed consent. Peripheral blood specimens were collected before vaccination and 4 weeks after vaccination; processed within 6 hours of collection for isolation of peripheral blood mononuclear cells (PBMCs), using Ficoll-Hypaque gradients; and cryopreserved in liquid nitrogen [19] . Plasma specimens were stored in aliquots at −80°C. Serologic analysis for influenza virus Ab was performed in 70 women (Table 1) , and a subgroup of 48 participants underwent immunologic assessments (Supplementary Table 1 ).
Serologic Assessments
Influenza virus Ab titers for H1N1/09 vaccine antigen (H1N1 A/California/07/2009 antigen, a gift from Novartis Vaccines and Diagnostics) were determined in plasma by a hemagglutination inhibition assay (HAI) [20] . Seroprotection was defined as an HAI titer of ≥1:40. Participants with a postvaccination titer of ≥1:40 and a ≥4-fold increase from the prevaccination titer were classified as vaccine responders.
Phenotypic and Functional Characterization of pTfh and B Cells
The following monoclonal Abs (mAbs) were used: CD3-AmCyan, Ki-67-PerCPCy5.5, CXCR5-AF647, CXCR3-PeCy5, CD20-APCCy7, CD21-PeCy5, IL-21R-APC (BD Biosciences), CD4-QDot655, CD8-QDot605, CD10-QDot605, biotinylated For functional characterization of cell subsets, PBMCs were stimulated with 5 µg/mL H1N1/09 vaccine antigen plus anti-CD28 mAb (1 µg/mL) for 12 hours at 37°C, and brefeldin A (10 µg/mL) was added for the last 7 hours of incubation. Cells were stained with ViViD and pTfh surface markers, fixed, permeabilized, and stained for intracellular IL-21. In other experiments, PBMCs were stimulated as above for 5 days with H1N1 antigen plus anti-CD28 mAb in the presence or absence of 50 ng/mL exogenous IL-21 (Life Technologies) [18] . The cells were analyzed for Ab-secreting cells in enzyme-linked immunosorbent spot (ELIspot) assays.
ELIspot Assays
PBMCs from the 5-day cultures were plated in wells coated with goat anti-human IgG (2 µg/mL, Jackson Immunoresearch) at 100 000 cells/well for 4 hours at 37°C and assayed for H1N1-specific IgG. Data are expressed as Ab-secreting cells/million PBMCs [21, 22] .
Cytokine Measurements
The cytokines tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6) were determined in appropriate dilutions of plasma, using Milliplex cytokine magnetic bead panel in the Magpix instrument (Luminex) [12] . Mean fluorescent intensities (MFIs) were analyzed with Milliplex Analyst Software (EMD Millipore), and cytokine levels are expressed as picograms per milliliter.
Statistical Analysis
Data were analyzed with Spearman correlation, linear regression, 1-way analysis of variance, and linear mixed models. Analysis of variance results are presented as means and standard deviations for planned comparisons among groups. The data are presented as scatter plots with regression lines and Spearman correlation coefficients with P values. Box and whisker plots are presented with the P values for planned comparisons of mean values before and after vaccination within groups and among groups within times before and after vaccination. The 2-tailed 0.05 level was used to determine statistical significance. GraphPad Prism (GraphPad Software) and SAS 9.3 (SAS Institute) were used for all analyses.
RESULTS
Ab Response to Influenza Vaccination Is Diminished With Aging and HIV Infection
Before and after vaccination, older and young HIV-infected participants had lower Ab titers than older and young HIVuninfected participants, respectively, with the older HIV-infected participants exhibiting the lowest titers among all groups ( Table 1 ). Only 25% of older HIV-infected had titers of ≥1:40 before vaccination, compared with 50%, 57%, and 69% of older uninfected, young infected, and young uninfected participants, respectively. Although seroprotection rates after vaccination were 55%, 75%, 93%, and 100% in older infected, older uninfected, young infected, and young uninfected participants, respectively (Table 1) , frequencies of response were equivalent in HIV-infected and HIV-uninfected older participants, highest in young uninfected participants, and intermediate in young infected participants. HAI influenza virus Ab titers after vaccination correlated inversely with age in both HIV-uninfected (P = .007) and HIV-infected (P = .04) groups ( Figure 1) .
For immunologic investigations, we selected equal numbers of participants (ie, 12) in the 4 groups, with roughly even distribution of responders and nonresponders (Supplementary Table 1 (Table 1) . P values were calculated from planned comparisons of general linear mixed model mean values. Correlation between HIV-infected subjects is indicated by the continuous line. The dashed line shows the correlation between the 2 variables when only the HIVuninfected participants were taken into account.
Frequencies and Function of Memory B Cells Are Impaired With Aging and HIV Infection
Among participants classified as responders, only the young HIV-uninfected women showed a consistent increase in frequencies of total and IL-21R + resting memory B cells ( Figure 2A and 2B), as well as in H1N1 antigen-specific Ab-secreting cells from before to after vaccination ( Figure 2C ). Young HIV-infected responders showed an increase in 2 of 3 characteristics: total resting memory B cells and H1N1-specific Ab-secreting cells.
The older HIV-uninfected responders had a significant increase only in the H1N1-specific Ab-secreting cells. The older HIVinfected responders did not show any of these changes, despite their responder classification. The nonresponders in all 4 groups did not show these B-cell changes from before to after vaccination. older uninfected participants, and 6 older infected participants) and nonresponders (5 young uninfected participants, 7 young infected participants, 6 older uninfected participants, and 6 older infected participants) before and after vaccination were thawed and rested overnight followed by staining with monoclonal antibody (Ab). Figure 4B ). This subset also correlated with HAI Ab titer ( Figure 4C ).
Exogenous IL-21 Supplementation Does Not Enhance B-Cell Function in Older HIV-Infected Nonresponders
Since we observed a correlation between H1N1-specific IL-21 induction in pTfh cells and influenza virus Ab titers, we performed ELIspot assays to investigate whether ex vivo IL-21 supplementation of HIN1 antigen-stimulated PBMC cultures would improve postvaccination B-cell responses. Except for the older HIV-infected participants, increases in H1N1-specific Ab-secreting cells were noted in all responders, as well as in nonresponders ( Figure 4D ). Figure 2A) . Plasma levels of TNF-α ( Figure 5B ) and IL-6 ( Figure 5C ) were higher in nonresponders, compared with responders, among older HIV-infected and HIVuninfected participants, and collectively, levels of both cytokines were higher in HIV-infected participants, compared with HIV-uninfected participants (Supplementary Figure 2B and Supplementary Figure 2C) . Frequencies of activated CD4 + T cells before vaccination were inversely correlated with the postvaccination frequencies of resting memory B cells ( Figure 5D ) and H1N1-specific Ab-secreting cells in both HIV-infected and HIV-uninfected participants ( Figure 5E ) and with pTfh cells in HIV-infected participants ( Figure 5F ). Plasma TNF-α levels before vaccination correlated inversely with postvaccination frequencies of resting memory B cells ( Figure 5G ), H1N1-specific Ab-secreting cells ( Figure 5H − pTfh-cell subset and hemagglutination inhibition (HAI) titers after vaccination. D, PBMCs obtained from participants before and after vaccination were cultured for 5 days with H1N1 antigen with or without recombinant IL-21 (50 ng/mL). After 5 days, cells were analyzed by a B-cell enzyme-linked immunosorbent spot assay. Abbreviation: IgG, immunoglobulin G.
We also performed independent correlations of age and vaccine-induced influenza HAI titer with frequencies of various B-cell and T-cell subsets, Ab-secreting cells (by means of ELIspot analysis), T-cell immune activation, and inflammatory cytokines ( 
DISCUSSION
Impaired immunity in the aging population and during HIV infection are independently considered to be responsible for suboptimal efficacy of current influenza vaccines [3, 24] . In this study, we used seasonal influenza vaccination to analyze pTfh-cell and B-cell function in HIV-infected and HIVuninfected older and young women. Seroprotection rates before and after vaccination were higher in the young women, and , and pTfh-cell frequencies (I) after vaccination. *P < .05, **P < .01, ***P < .001, and ****P < .0001. Abbreviation: IgG, immunoglobulin G.
these participants also demonstrated stronger B-cell and pTfh-cell immune responses, reiterating the negative impact of aging on immunity. Among the various groups, the young HIV-uninfected participants had highest Ab response and best overall cellular functions, while the older HIV-infected participants exhibited the lowest and poorest responses in these assays. The IL21R + B-cell frequencies and H1N1-specific Absecreting cell responses in older HIV-uninfected participants were similar to those in young HIV-infected participants, implying acceleration of immune senescence with HIV infection in the latter group [25] . Interestingly, underlying immune activation was the most prominent feature differentiating HIV-infected from HIV-uninfected nonresponders in both age groups, while decreased IL-21 production by pTfh cells after vaccination was consistently associated with a poor Ab response. These findings point to immune activation and deficient pTfh-cell function as leading factors for impaired responsiveness to influenza vaccines and favor the contention that immunologic decline in aging is hastened by the presence of immune activation associated with HIV infection. To understand the immunologic basis of impaired Ab responses, we selected roughly equal numbers of young and older HIV-infected and HIV-uninfected vaccine responders and nonresponders and evaluated their B-cell and T-cell responses and plasma biomarkers. We have previously shown that certain B-cell characteristics, such as frequency and function of memory B cells and expression of IL-21R, are correlated with the magnitude of vaccine-induced serologic Ab responses in HIV-infected young adults [21] . Our study shows that, after vaccination, influenza virus HAI titer, frequencies of memory B cells, IL-21R expression, and H1N1 antigen-induced Absecreting cell responses, were negatively and independently influenced by age and HIV infection. Although the effect of age dominated, that of HIV infection was also significant. Considered in the context of responder/nonresponder status, positive changes from before to after vaccination in the 3 B-cell characteristicsfrequencies of memory B cells, IL-21R expression, and H1N1 antigen-induced Ab-secreting cells-were most clearly evident in young HIV-uninfected responders and less so in young HIV-infected responders and were never seen in nonresponders in either age group, regardless of HIV infection status. Older participants had demonstrable deficiencies in these B-cell features, most evident in the older HIV-infected participants, even in those classified as responders. The cause for the failure of expansion of memory B cells and antigen-induced Ab-secreting cells after vaccination is unclear; recruitment of B cells may be impaired because the naive B-cell pool is depleted as a result of preexisting memory B-cell expansion by repeated prior antigenic stimulation or nonspecific activation by inflammatory cytokines.
Tfh cells provide critical help in the germinal centers for B-cell differentiation and plasma cell generation [13, 26] , and defective expansion of pTfh cells after vaccination is an indicator of influenza vaccine nonresponsiveness in HIV-infected persons [18, 21, 27] . In this study, we found that frequencies of pTfh cells and IL-21 + pTfh cells and expression of ICOS were positively correlated with HAI titer and negatively correlated with age. We also observed that pTfh-cell expansion after vaccination correlated with B-cell memory responses in both young and older groups, confirming prior observations that support the [27] [28] [29] . ICOS is known to regulate IL-21 production and the proliferation and function of Tfh cells [30, 31] and is essential for immunoglobulin secretion from human B cells in vitro [18, 30, 32] . Defects in ICOS expression on CD4 + T cells have been described in individuals with advanced age [33, 34] . The older HIV-infected group had the poorest cellular functions of pTfh cells, as well as of B cells, as discussed above. The severity of their impairment was evident also in the failure of exogenous IL-21 to augment antigenspecific B-cell Ab secretion in ELIspot assays in the older infected nonresponders. These observations add to the increasing body of evidence that aging adversely influences the ability of pTfh cells to expand after immunization, possibly affecting their survival, maintenance, or renewal [35, 36] . Our findings imply that the presence of HIV infection compromises the aging immune system, even when viremia is adequately controlled. The nature of pTfh cells that are responsible for B-cell help is being intensively investigated [17, 23, 26, 37] . A PD1 + CXCR3
− memory pTfh-cell subset is believed to originate in germinal centers of lymph nodes and serve as the prime helper pTfhcell subset [23] . We found a correlation of this pTfh-cell subset with influenza vaccine-induced Ab responses and an inverse correlation with age, similar to total CXCR5 + memory pTfh cells. The role of this and other newly described pTfh-cell subsets [38] in driving the changes in Ab responses needs to be investigated in aging and HIV infection. Immune activation and inflammation are hallmarks of aging [11, 39] , as well as of HIV infection [12] , but their role in influencing vaccine-induced responses is less clear. We previously showed that activated CD4 + T cells and elevated levels of the inflammatory cytokine TNF-α were associated with poor Ab responses to vaccination in HIV-infected subjects [5] . In the present study, we observed that the activated CD4 + T cells had an inverse relationship with expansion of antigen-specific resting memory B cells in both HIV-infected and HIV-uninfected participants, implying an independent influence of aging on CD4 + T-cell immune activation and immune response. An elevated TNF-α level compromises B-cell function in vitro both in aged and young mice [40] . Long-term exposure of T cells to TNF-α impairs T-cell proliferation and cytokine production [41, 42] , and T cells are rescued by blocking production of this cytokine [43] . Here, we noted that baseline plasma TNF-α levels correlated with activated CD4 + T cells and were negatively associated with expansion of IL-21R + resting memory B cells, pTfh-cell expansion, and IL-21 production. An increased TNF-α level in nonresponders, compared with responders, in the older infected and older uninfected groups points to the role of inflammation in blunting the vaccine response during aging. IL-6 is known to contribute to inflammation and disease conditions in elderly individuals [44, 45] , and here the predominant finding was that of increased IL-6 levels in older infected nonresponders. We have tried to compensate for the small sample size by including women only, to prevent confounding influence of hormonal differences, with equivalent numbers of young and older participants and of HIV-infected and HIV-uninfected participants and an even distribution of classifiable responders and nonresponders. Despite study limitations, we were able to observe clear differences between the older and young participants within HIVinfected and HIV-uninfected participants, implying that aging and HIV infection together are severely detrimental to the immune system, exceeding the effects of each by itself. Our data point to a similarity between the young HIV-infected and older HIV-uninfected participants in cellular immunologic measures of vaccine-induced immune responses, reinforcing the premise that HIV infection accelerates aging of the immune system [25] . Further, defects attributable to impaired pTfh cells and persistent aberrant immune activation point to these entities as strategic targets for improving influenza vaccine responses in virologically suppressed aging HIVinfected populations. The recent recommendationsto use high-dose influenza vaccine in elderly individuals [46, 47] may also be beneficial for the HIV-infected population and warrants investigation.
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